Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Karen Y Kuo"'
Publikováno v:
Journal of Investigative Dermatology. 138:1209-1212
Autor:
Hyunje G. Cho, Mina S. Ally, Karen Y Kuo, Elizabeth E. Bailey, Sarah L. Sheu, Jinah Kim, Bernice Y. Kwong
Publikováno v:
Acta Haematologica. 138:33-38
Background/Aims: This study examined the role of random normal skin biopsy in the diagnosis of intravascular lymphoma (IVL) in adult Western patients with clinically diagnosed hemophagocytic lymphohistiocytosis (HLH). Methods: In a retrospective char
Autor:
Karen Y. Kuo, Jean Y. Tang, Anne Lynn S. Chang, Kavita Y. Sarin, Anthony E. Oro, Sumaira Z. Aasi, Irene Bailey, Shufeng Li, Hyunje G. Cho
Publikováno v:
JCI insight. 3(15)
Innate DNA repair mechanisms play a critical role in protecting skin keratinocytes from UV mutagenesis and skin cancer development. We hypothesized that individuals who develop frequent skin cancers may harbor germline defects in DNA repair genes and
Autor:
Kerri E. Rieger, Karen Y. Kuo, Jean Y. Tang, Hyunje G. Cho, Shufeng Li, Kavita Y. Sarin, Prag Batra, Harvind S. Chahal
Publikováno v:
Journal of the American Academy of Dermatology. 77(2)
Autor:
Anne Lynn S. Chang, Sumaira Z. Aasi, Anthony E. Oro, Jean Y. Tang, Hyunje G. Cho, Karen Y. Kuo, I. Bailey-Healy, Kavita Y. Sarin, Ervin H. Epstein, Shaoying Li
Publikováno v:
Journal of Investigative Dermatology. 138:S28
Autor:
Karen Y. Kuo, Kavita Y. Sarin, Jean Y. Tang, Hyunje G. Cho, Katherine Xiao, Shufeng Li, Prag Batra
Publikováno v:
Journal of the American Academy of Dermatology. 78:27-28.e1
Publikováno v:
Journal of Investigative Dermatology. 137:S18
Autor:
Kerri E. Rieger, Kavita Y. Sarin, Prag Batra, Shaoying Li, Jean Y. Tang, Karen Y. Kuo, Hyunje G. Cho
Publikováno v:
Journal of Investigative Dermatology. 137:S30
Autor:
Anthony E. Oro, Karen Y. Kuo, Shaoying Li, Harvind S. Chahal, A.S. Chang, Jean Y. Tang, Kavita Y. Sarin, Kerri E. Rieger, Prag Batra
Publikováno v:
Journal of Investigative Dermatology. 136:B5
Publikováno v:
JAAD Case Reports
Ipilimumab, an immune checkpoint inhibitor, is approved for the treatment of advanced melanoma. Its potential activity in keratinocytic cancers, however, is not well known. We present a case of a man in his 60s with advanced basal cell carcinoma (BCC